Comparison of two methods for tumour-targeting peptide modification of liposomes.

Acta Pharmacol Sin

Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy; College of Polymer Science and Engineering; Med-X Center for Materials, Sichuan University, Chengdu, 610041, China.

Published: April 2023

AI Article Synopsis

  • Liposomes modified with the TR peptide, which targets specific tumour cells, improve drug delivery efficiency in cancer treatments by utilizing two methods for peptide attachment: linking with cysteine residue or incorporating a stearyl chain.
  • These modifications lead to enhanced liposome surface charge changes in the acidic tumour environment, resulting in better cellular uptake of drugs compared to unmodified versions.
  • In mouse models, liposomes containing the modified peptides significantly reduce tumour size more effectively than standard liposomes, indicating that the choice of modification method critically impacts treatment outcomes.

Article Abstract

Liposomes decorated with tumour-targeting cell-penetrating peptides can enhance specific drug delivery at the tumour site. The TR peptide, c(RGDfK)-AGYLLGHINLHHLAHL(Aib)HHIL, is pH-sensitive and actively targets tumour cells that overexpress integrin receptor αβ, such as B16F10 melanoma cells. Liposomes can be modified with the TR peptide by two different methods: utilization of the cysteine residue on TR to link DSPE-PEG2000-Mal contained in the liposome formula (LIP) or decoration of TR with a C18 stearyl chain (C18-TR) for direct insertion into the liposomal phospholipid bilayer through electrostatic and hydrophobic interactions (LIP). We found that both TR and C18-TR effectively reversed the surface charge of the liposomes when the systems encountered the low pH of the tumour microenvironment, but LIP exhibited a greater increase in the charge, which led to higher cellular uptake efficiency. Correspondingly, the IC values of PTX-LIP and PTX-LIP in B16F10 cells in vitro were 2.1-fold and 2.5-fold lower than that of the unmodified PTX-loaded liposomes (PTX-LIP), respectively, in an acidic microenvironment (pH 6.3). In B16F10 tumour-bearing mice, intravenous administration of PTX-LIP and PTX-LIP (8 mg/kg PTX every other day for a total of 4 injections) caused tumour reduction ratios of 39.4% and 56.1%, respectively, compared to 20.8% after PTX-LIP administration. Thus, we demonstrated that TR peptide modification could improve the antitumour efficiency of liposomal delivery systems, with C18-TR presenting significantly better results. After investigating different modification methods, our data show that selecting an adequate method is vital even when the same molecule is used for decoration.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043035PMC
http://dx.doi.org/10.1038/s41401-022-01011-4DOI Listing

Publication Analysis

Top Keywords

peptide modification
8
ptx-lip ptx-lip
8
ptx-lip
6
liposomes
5
comparison methods
4
methods tumour-targeting
4
peptide
4
tumour-targeting peptide
4
modification liposomes
4
liposomes liposomes
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!